Stefan Nilsson, Ph.D.CEO at Lipigon Pharmaceuticals AB
Stefan K. Nilsson, PhD, MSc, MBA, is the CEO and founder of Lipigon Pharmaceuticals AB ($LPGO). Nilsson had his training in Prof. Gunilla Olivecrona’s group and earned his PhD 2010 on novel factors affecting triacylglycerol clearance. Nilsson continued as assistant professor and junior group leader at UmU. After a sabbatical year at Hamburg University UKE as guest scientist in Prof. Joerg Heeren’s group he became fulltime CEO at Lipigon 2016. Academic merit includes publications in high ranking journals such as Lancet and Cell Metabolism. Business merit includes successful IPO of Lipigon at Nasdaq First North GM and several research collaboration deals with e.g. AstraZeneca and HitGen Inc.